Radcliffe Capital Management L.P. Takes $1.23 Million Position in Pacira BioSciences, Inc. $PCRX
Radcliffe Capital Management L.P. bought a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F...